Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: A multicenter study of 951 bone marrow samples with lymphomatous infiltration

American Journal of Clinical Pathology

Volumn 132, Issue 2, 2009, Pages 186-190

  Carulli, Giovanni ^a,e   Stacchini, Alessandra ^b   Marini, Alessandra ^c   Ciriello, Maria Matilde ^d   Zucca, Alessandra ^a   Cannizzo, Elisa ^a   Aliberti, Sabrina ^b   Demurtas, Anna ^b   Novero, Domenico ^b   Calcagno, Lara ^d   Callegari, Tiziana ^d   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Versilia Hospital   (Italy)

^d C Arrigo Children's Hospital   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

B cell chronic lymphocytic leukemia; CD8; Flow cytometry; Non Hodgkin lymphoma

Indexed keywords

CD5 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW BIOPSY; CANCER INCIDENCE; FEMALE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD19; ANTIGENS, CD5; ANTIGENS, CD8; BONE MARROW; FLOW CYTOMETRY; HUMANS; LYMPHOMA, B-CELL; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 68549101903     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPNCOHS92ARWRQ     Document Type: Article

References (25)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma group. Blood. 1994;84:1361-1392.
2. Barry TS, Jaffe ES, Kingma DW, et al. CD5+ follicular lymphoma: a clinicopathologic study of three cases. Am J Clin Pathol. 2002;118:589-598.
3. Kume M, Suzuki R, Yatabe Y, et al. Somatic hypermutation in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Jpn J Cancer Res. 1997;88:1087-1093.
4. Inaba T, Shimazaki C, Sumikuma T, et al. Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma. Br J Haematol. 2000;109:592-599.
5. Kampalath B, Barcos MP, Stewart C. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic leukemia. Am J Clin Pathol. 2003;119:824-832.
6. Mulligan SP, Dao LP, Francis SE, et al. B-cell chronic lymphocytic leukemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen. Br J Haematol. 1998;103:157-162.
7. Cannizzo E, Carulli G, Zucca A, et al. CD19/CD8 coexpression in B-chronic lymphocytic leukemia. Acta Haematol. 2007;117:128.
8. Parisi-Duchene E, Mazurier I, Moskovtchenko P. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases. Acta Haematol. 2006;115:74-77.
9. Richaud-Patin Y, Piedras J, Carrillo-Maravilla E, et al. CD8+ chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia. Eur J Haematol. 2003;71:224-230.
10. Espinosa A, Bjork P, Magnussen K, et al. Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia. Leuk Lymphoma. 2003;44:193-196.
11. Brunet C, Bardin N, Oukhouya O, et al. A case report: CD8 expression in B-cell chronic lymphocytic leukemia (B-CLL): prognostic significance of the aberrant CD8 expression. Hematol Cell Ther. 1998;40:279-282.
12. Gosh K, Sivakumaran M, Wood JK. Aberrant CD8 antigen expression in a patient with B chronic lymphocytic leukaemia showing unusual disease progression. Br J Haematol. 1993;85:205-206.
13. Islam A, Vladutiu AO, Donahue T, et al. CD8 expression on B cells in chronic lymphocytic leukemia: a case report and review of the literature. Arch Pathol Lab Med. 2000;124:1361-1363.
14. Hoffman DG, Tucker SJ, Emmanoulides C, et al. CD8-positive mantle cell lymphoma: a report of two cases. Am J Clin Pathol. 1998;109:689-694.
15. Schroers R, Hildebrandt Y, Steffens R, et al. Immunophenotypic and genetic characterization of CD8 positive mantle cell lymphoma in a patient with concomitant mycosis fungoides. Eur J Haematol. 2005;75:78-84.
16. Carulli G, Canigiani S, Volpini M, et al. Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy [in Italian]. Recent Prog Med. 2005;96:284-290.
17. Stacchini A, Demurtas A, Godio L, et al. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-18.
18. Galimberti S, Brizzi F, Mameli M, et al. An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease. Leuk Res. 1999;23:921-929.
19. Van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
20. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10:877-895.
21. Kaleem Z, White G, Zutter MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol. 2001;115:396-403.
22. Jani P, Qi XY, Chang H. Aberrant expression of T-cell-associated markers CD4 and CD7 on B-cell chronic lymphocytic leukemia. Am J Hematol. 2007;82:73-76.
23. Katsura Y. Redefinition of lymphoid progenitors. Nat Rev Immunol. 2002;2:127-132.
24. Chen W, Asplund SL, McKenna RW, et al. Characterization of incidentally identified minute clonal B-lymphocytes in peripheral blood and bone marrow. Am J Clin Pathol. 2004;122:588-595.
25. Caligaris-Cappio F, Ghia P. The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model. Hematol Oncol Clin North Am. 2004;18:849-862.